(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 10.19% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.61%.
Sight Sciences's revenue in 2026 is $79,553,000.On average, 9 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,700,366,069, with the lowest SGHT revenue forecast at $4,441,701,205, and the highest SGHT revenue forecast at $4,882,312,916. On average, 9 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,188,749,709, with the lowest SGHT revenue forecast at $4,505,687,297, and the highest SGHT revenue forecast at $5,708,147,015.
In 2028, SGHT is forecast to generate $5,905,111,005 in revenue, with the lowest revenue forecast at $5,398,119,166 and the highest revenue forecast at $6,237,011,651.